Assemble Clinical, Financial, and Operational Venture Data
The founder aggregates all internal clinical data, cost-effectiveness assumptions, current unit economics, and operational impact metrics. They compile comparative care-pathway costs, current standard-of-care price points, and preliminary clinical trial efficacy figures.
Consolidating baseline data provides the foundational inputs required to build a defensible economic model. This prevents reliance on unsubstantiated assumptions when proving financial value to risk-averse healthcare procurement teams, protecting the venture's credibility.
A structured repository of baseline parameters including current pathway costs, staff time, length of stay, device costs, and relevant clinical endpoints. All figures must be backed by published literature, institutional cost databases, or audited internal trial data.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
What primary data sources substantiate your current baseline standard-of-care cost estimates?
- 2
How robust are the clinical efficacy assumptions underpinning your projected economic benefits?
- 3
Where are the critical data gaps in your operational impact metrics, and how do you plan to plug them?
- 4
How have you adjusted your financial inputs for variations in pathway implementation across different hospital trusts?
- 5
Which key cost drivers in your model are most sensitive to changes in real-world clinical adoption?